Arkolith/Insider Trading/GLUE/Form 4

Behbahani Ali

DirectorMonte Rosa Therapeutics, Inc. (GLUE) · full profile →Form 4 · filed Jul 6, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2026Other(J)1.0M—$06.7M
Jul 1, 2026Other(J)15K—$015K
Jul 1, 2026Other(J)15K—$00

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-296490) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML